iDCtWT1

N/A

Report date: 2025/01/26 18:35:05

Base Information

Drug NameiDCtWT1
Drug Alias Nametricistronic integrase-defective lentiviral vector gene therapy (Kings college London/Hannover medical School)
ClassificationBiologics
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor modulatorsWilms' Tumour 1 stimulantsInterferon alpha ligand
TargetsWilms' Tumour 1Granulocyte-macrophage colony-stimulating factor receptorInterferon alpha
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesMedizinische Hochschule HannoverKing'S College London
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A